Ohio Scientists Determine Asbestos Causes Cancer

LegalView Reports Development of a Breakthrough Study Explaining How Asbestos Causes Mesothelioma Cancer

LegalView recently reported of a study by scientists at Ohio State University who are attempting to determine the molecular details of how asbestos fibers bind to human cancer cells. The scientists hope that with the study, they will eventually be able to produce more adequate mesothelioma treatments.

Denver, CO, January 01 -- LegalView.com, the most comprehensive legal resource available on the Internet, recently informed its mesothelioma information blog readers of the development of a breakthrough study by Ohio State University researchers as to how asbestos fibers bind to human cells to cause the deadly condition known as mesothelioma. The scientists will be using a method known as atomic force microscopy "to observe how a single asbestos fiber binds with a specific receptor protein on cell surfaces," according to a Dec. 22 Science Daily news article. Although the study is years away from being complete, scientists hope that one day they may be able to offer a better understanding of the development of the condition, which will result in a more comprehensive knowledge of the disease and more adequate treatments.

Mesothelioma cancer is a condition that occurs in individuals who have inhaled asbestos fibers and/or dust. The condition causes cancerous cells to form on the internal lining of the lungs and, after 10 to 30 years, signs and symptoms of the condition begin to develop. Because mesothelioma cancer remains largely in a dormant state for the duration of its life in a victim, by the time its symptoms develop it is often untreatable.

Individuals who suffer from the deadly cancer should consider speaking with an experienced mesothelioma lawyer as to the details surrounding a potential mesothelioma lawsuit. Such a meeting could benefit anyone suffering from mesothelioma symptoms by resulting in monetary compensation, which may assist a victim in receiving expensive and potentially life-saving treatments.

LegalView also offers an array of other legal topics available through its LegalView library. For example, the site has made available the latest information on brain injury treatments as well as information on controversial prescription drugs such as Chantix and Singulair, which have both been linked to suicidal thoughts and tendencies among patients, according to U.S. Food and Drug Administration reports.

LegalView recently updated its TBI information portal with a new therapy known as hyperbaric oxygen therapy (HBOT), which is often used among divers when bends occur. However, new research is finding that HBOT may offer success among brain injured victims by administering the therapy among U.S. soldiers as a brain injury treatment. To learn more of the treatment, visit the LegalView brain injury information portal at http://brain-injury.legalview.com/.

Both Chantix and Singulair have been linked to an increase of behavioral and mood disorders as well as depression, increased suicidal tendencies, thoughts and actions; although both drugs treat very different conditions. Chantix is a smoking cessation drug that has been prescribed to nearly 4 million U.S. citizens whereas Singulair is used to treat allergies and asthma among Americans. If a victim suffers from either the Chantix risks or the Singulair side effects, they are encouraged to locate an experienced pharmaceutical attorney for assistance on developing a potential class action lawsuit.

About LegalView

LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com.

Contact Information
LegalView
Katie Kelley
720-226-6613
press-releases@legalview.com
http://mesothelioma.legalview.com

Support for Mesothelioma Searchers

LegalView Announces Support for Mesothelioma Searchers

LegalView.com continues to support mesothelioma and asbestos bloggers with their mesothelioma search tool.

Denver, CO, October 08, 2009 -- LegalView.com, a leader among personal injury legal websites, has been diligently updating their informational resources on the topics of mesothelioma, construction accidents, as well as several other resource portals on their site. One of the most notable and helpful services LegalView provides is that of their mesothelioma search engine, available at http://mesothelioma.legalview.com/mesothelioma-search/. This tool provides an invaluable resource to anyone seeking information on mesothelioma, asbestos exposure, asbestosis or looking to find a asbestos attorney. The search engine scours several news services, proven academic and scientific sites, mesothelioma blogs, and pharmaceutical websites for the most recent and pertinent information and condenses it into an approachable and clean presentation, offering the user a combination of volume and manageability.

This search engine service can be used extensively by individuals either afflicted with an asbestos-related ailment or seeking resources for a family member. However, this search engine can be beneficial for another group of individuals seeking current information regarding mesothelioma treatments as well. Asbestos and mesothelioma bloggers can utilize LegalView's search engine to condense the massive amount of information available on the topic. With continued research, medical studies, clinical pharmaceutical trials, not to mention developments across the United States concerning various potential mesothelioma settlement cases, LegalView's easy-to-use search engine offers bloggers an opportunity to take much of the hassle of acquiring the latest developments in the mesothelioma world.

Asbestos bloggers have a difficult time finding useful and relevant information through most conventional search engines; much of the material these services return is irrelevant, providing information about the most basic function of asbestos, where to find it, and the dangers present from exposure to this toxic substance. There is also the additionally frustrating search result of receiving search results that have already been used in previous entries. Since LegalView offers the mesothelioma search engine free of charge, many bloggers can celebrate an additional resource to help them in their work.

Since a mesothelioma diagnosis often offers a grim prognosis, many individuals seeking further information or resources on the topic consult the vast knowledge base of the Internet. However, outside of a few select, professional mesothelioma sites, most are often stymied by the overwhelming search results, misleading pages, or outdated sites. Not only does LegalView provide an easily accessed search resource for mesothelioma, but also provides users with a form for contacting a mesothelioma lawyer to help with developing a potential mesothelioma lawsuit.

The depth and range of web pages, journals, and medical research that the LegalView search engine scours provides an unmatched resource for those seeking access to any information regarding mesothelioma. Often, this level of access could require a membership on other websites, as the resources invested in such a powerful tool are of significant worth. However, on the LegalView website, not only are users provided with this service free of charge, but also are provided with a contact form to help users find an experienced mesothelioma lawyer free of charge.

About LegalView:

Legalview.info is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of Legalview.info's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.Legalview.info.

Contact Information
LegalView
Ryan Smith
720-226-6613
press-releases@legalview.com
http://mesothelioma.legalview.com

Understanding Types Of Malignant Mesothelioma

Understanding the Epithelial, Surcomatoid and the Biphasic types of the malignant mesothelioma

2009-07-22 - (mesotheliomacancernews.com - Mesothelioma Press Release) - Dallas, TX - Facts about mesothelioma cancer are fairly known to many and specially to those who are affected with mesothelioma cancer. Yet, with this rare disease harming those who have been closely associated with asbestos, exposing themselves to asbestos fibers at their work place or through the family members who brought the dust of silver fiber at home in the work cloths, shoes, hair while returing from work.

The fact noted here is that no one who comes into contact with asbestos is spared from its lethal effects whether its is a direct asbestos industry workers or the worker of the industry that produces goods in which asbestos is used as a raw material and the family members, their friends and loved ones of these workers. Thus, the number of people who get effected from asbestos fibers easily and surely multiplies.

Epithelial mesothelioma, Sarcomatoid mesothelioma, malignant biphasic mesothelioma

1) The Epithelial mesothelioma: Approximately 50% to 70% of mesothelioma cells are the epithelial cells. These cells are tubular in pattern and are of uniform shape. These cells develop in the mesothelioma that protects certain organs of the gastrointestinal tract and the lungs.

Treatment of these epithelial cells is based on the three traditional therapies of surgery, radiation and chemotherapy. Sometimes, two therapies are combined for the treatment, depending upon the intensity of the infection.

2) The sarcomatoid mesothelioma: These cells are irregular and oval in shape. The nucleus is difficult to detect. These cells further divide into secondary cells and are classified as the 'acinar 'cells, the' clear'' cells and the 'tubo-papillary' cells. About 10% to 15% of the total mesothelioma cancer patients belong to this class of cells. This type of the cells lead towards death.

The treatment is the same as of the mesothelioma epithelial cells. But, these sarcomatoid cells are very resistant to these treatments. Help of other therapies such as the immunotherapy, the gene therapy and the photodynamic therapy proves helpful.

3) The malignant biphasic mesothelioma: 40% to 60% of the mesothelioma cancer patients belong to this class, The biphasic system is a combination of both the epithelial and the sarcomatoid types of mesothelioma.

Treatment is the same as prescribes for the above two types, with a few variations, depending upon the stage and level of the disease.

Thus, with the knowledge and the development in treatment and therapies, the sad part is, that all mesothelioma cancer cases are fatal.

 

 

 

Drug Toxicity Assay Kits Increase Drug Development Efficiency

Bioo Scientific's Toxicity Assay Kits Increase the Efficiency of Drug Development

Bioo Scientific announced the launch of the MaxDiscoveryT Toxicity Assay Kits for the monitoring of toxic effects in in vivo preclinical studies.

Austin, TX, May 31, 2009 -- Since toxicity is one of the leading causes of drug failures, measuring preclinical toxicity is a critical drug development function. Accurate in vivo toxicity assays are essential to lowering attrition and increasing efficiency in drug development.

Bioo Scientific announced today the launch of their MaxDiscoveryT Toxicity Assay Kits. These kits monitor in vivo toxicity by measuring liver and heart function in serum samples. They provide simple, convenient, colorimetric determination of well-characterized functional markers of for liver and heart. They are ideal tools to monitor toxic effects caused by administration of siRNA, DNA plasmids, transfection agents or other therapeutic treatments during preclinical studies. The assays can be used in a range of mammals, including mice and rats, providing a powerful tool to assess and reduce the toxicity of drugs formulations and to improve drug delivery methods.

According to Dr Joe Krebs, Director of Protein Chemistry and Engineering at Bioo Scientific, "MaxDiscoveryT Toxicity kits are designed to provide researchers with rapid, cost-effective tools required to address the escalating challenges of drug development in today's competitive landscape."

Assays are available for alanine transaminase, aspartate transminase, alkaline phosphatase, lactate dehydrogenase, cholesterol, and creatine kinase.

About Bioo Scientific
Bioo Scientific Corporation is a global biotechnology tools company, headquartered in Austin, Texas. Bioo Scientific provides innovative products and services to academic researchers, pharmaceutical and biotechnology companies, molecular diagnostics laboratories, and customers who perform food and feed safety analysis.

Contact Information
Bioo Scientific
Dawn Obermoeller
512-301-4094
dawn@redbridgemarketing.com
www.biooscientific.com

Truck Drivers At Greater Risk For Lung Cancer

Diesel Users Suffer More Lung Cancer; a Simple Solution is to Hand from ChemEcol and VEPower

Those who work with and at close proximity to diesel engines, especially lorry drivers, are at a higher risk of cancer according to a recent US study. This is on top of the elevated risk of "heart disease and stroke, possibly resulting from enhanced coagulation and arterial thrombosis" such exposure gives. The good news is that a British company has developed a fuel technology that is seen to significantly reduce ultra fine particulate emissions by as much as 45%.

Welwyn Garden City, United Kingdom, March 28, 2009 -- Truckers endure such grave risks as lung cancers, heart disease and stroke all the time they run their engines. But it's not just the lorry drivers who are at risk. The American study also saw that those working with the and near trucks (fork truck drivers, warehousemen, mechanics, and even office workers) are at elevated risk from these killers. Why?

Diesel exhaust carries particulate matter; this is what colours it smoky black. Particulates are both created by and carriers of toxic substances called polycyclic aromatic hydrocarbons (PAHs). Many of these are known to be particularly carcinogenic, mutagenic. Some of these particles are small enough (100nm or less) to be classified as nanoparticles. These have been found to become distributed around the body via the blood supply once inhaled with notable deposits being found in the liver and heart. If ingested (when particles have settled on food or in drink) they will also pass into the gastro-intestinal tract (4).

It's not just haulage workers and their colleagues who are at risk. Black carbon (again, part of the exhaust) exposure in city children has been shown to reduce development in terms of intelligence (5). The particulate matter we have been looking at is known also to exacerbate respiratory complaints, allergies such as asthma and may agitate some skin complaints also. Some studies have found that certain particulate constituents can be carcinogenic on the skin as well as when inhaled (6).

ChemEcol (UK) Ltd. makes the combustion enhancer Additone. The technology has been developed as a response to the grave threats posed by vehicle exhaust pollution. ChemEcol's products are not based on metallic catalysts, nano-technology or otherwise, as such would counteract the goal of reducing particulate pollutant emissions (the metallic particles would be exhausted along with the other emissions). In fact this technology is based on pure hydrocarbon formulations, maintaining the physical properties of the diesel.

ChemEcol's patented technology modifies the processes of fuel combustion inside the engine, reducing the particulates produced at the most fundamental level. This has a beneficial side-effect of reducing fuel consumption as the PAHs otherwise produced can be considered to be wasted fuel. This change then reduces CO2 emissions and costs by an average of 3%.

VEPower Ltd markets ChemEcol's product. They can be reached at ChemEcol on +44 (0) 1707 330400, at www.chemecol.net and neil@chemecol.net.

Contact Information
ChemEcol Ltd
Nel Faulkner
+44 (0) 20 3286 8771
neil@chemecol.net
www.chemecol.net